• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ionis Pharmaceuticals, Inc. - Common Stock (NQ:IONS)

63.57 +1.53 (+2.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,431,564
Open 62.53
Bid (Size) 63.55 (100)
Ask (Size) 64.00 (1,500)
Prev. Close 62.04
Today's Range 62.19 - 64.19
52wk Range 41.70 - 86.74
Shares Outstanding 141,797,854
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Breakfast News: A Conversation With Ionis CEO ↗
August 22, 2026
Ionis Pharmaceuticals CEO on a major profitability milestone, breakthrough medicines and more. 
Via The Motley Fool
Topics ETFs World Trade
News headline image
Ionis to present new data strengthening leadership in the management of severe hypertriglyceridemia (sHTG) at the European Society of Cardiology Congress 2026
August 20, 2026
From Ionis Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
-20.2%
-20.2%
1 Month
+13.6%
+13.6%
3 Month
-16.4%
-16.4%
6 Month
-24.9%
-24.9%
1 Year
+52.0%
+52.0%

More News

Read More
News headline image
Why the Alnylam Sell-Off Looks Overdone -- and What Investors Are Missing ↗
August 16, 2026
Via The Motley Fool
Ionis Pharmaceuticals (NASDAQ:IONS) Surges After Q2 Earnings Beat Estimates ↗
July 29, 2026
Via Chartmill
Topics Earnings
News headline image
Ionis Stock Has Plunged 30%. Is It Time to Buy the Beaten-Down Stock? ↗
August 14, 2026
Via The Motley Fool
News headline image
IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law
August 08, 2026
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
Ionis (IONS) Q2 2026 Earnings Call Transcript ↗
August 07, 2026
Via The Motley Fool
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
August 04, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Ionis Pharmaceuticals Director Hayden Buys $1.1 Million Shares. What Does This Mean for Investors? ↗
August 03, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Ionis Pharmaceuticals Q2 Earnings Call Highlights ↗
July 29, 2026
Via MarketBeat
Topics Earnings
News headline image
Ionis announces Dr. Frank Bennett, chief scientific officer, to retire
July 29, 2026
From Ionis Pharmaceuticals, Inc.
Via Business Wire
News headline image
Ionis reports second quarter 2026 financial results and highlights progress on key programs
July 29, 2026
From Ionis Pharmaceuticals, Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
July 28, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
July 21, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Cathie Wood Just Bet Big on This Biotech Stock ↗
July 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
Ionis to hold second quarter 2026 financial results webcast
July 15, 2026
From Ionis Pharmaceuticals, Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
July 14, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
July 14, 2026
From Ionis Pharmaceuticals, Inc.
Via Business Wire
News headline image
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions ↗
July 13, 2026
Via MarketBeat
News headline image
IONS Investor Alert: Levi & Korsinsky Notifies Investors of an Investigation Into Ionis Pharmaceuticals (IONS)
July 13, 2026
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
July 13, 2026
From Ionis Pharmaceuticals, Inc.
Via Business Wire
Which stocks are experiencing notable movement on Thursday? ↗
July 09, 2026
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
July 09, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
July 09, 2026
Via Chartmill
Discover the top movers in Thursday's pre-market session. ↗
July 09, 2026
Via Chartmill

Frequently Asked Questions

Is Ionis Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Ionis Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Ionis Pharmaceuticals, Inc. - Common Stock trade on?
Ionis Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ionis Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Ionis Pharmaceuticals, Inc. - Common Stock is IONS on the Nasdaq Stock Market
What is the current price of Ionis Pharmaceuticals, Inc. - Common Stock?
The current price of Ionis Pharmaceuticals, Inc. - Common Stock is 63.57
When was Ionis Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Ionis Pharmaceuticals, Inc. - Common Stock was at 08/25/26 04:00 PM ET
What is the market capitalization of Ionis Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Ionis Pharmaceuticals, Inc. - Common Stock is 9.01B
How many shares of Ionis Pharmaceuticals, Inc. - Common Stock are outstanding?
Ionis Pharmaceuticals, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap